EGFR-targeted fluorescent imaging has been tested in clinical trials for several types of cancer, including head and neck cancer [25], pancreatic cancer [26], glioblastoma and glioma [13, 27], oral cancer [28], and lung cancer [13]. Here, EGFR is linked to glioma.